S'abonner

Associations between outdoor fungal spores and childhood and adolescent asthma hospitalizations - 19/04/17

Doi : 10.1016/j.jaci.2016.06.046 
Rachel Tham, MPH, MHSc a, Don Vicendese, PhD b, Shyamali C. Dharmage, PhD a, Rob J. Hyndman, PhD c, Ed Newbigin, PhD d, Emma Lewis, MSc d, Molly O'Sullivan, B Appl Sc (Hons) e, Adrian J. Lowe, PhD a, e, Philip Taylor, PhD f, Philip Bardin, PhD g, Mimi L.K. Tang, PhD a, e, h, Michael J. Abramson, PhD i, Bircan Erbas, PhD b,
a Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, the University of Melbourne, Melbourne, Australia 
b School of Public Health, College of Science, Health and Engineering, La Trobe University, Bundoora, Victoria, Australia 
c Department of Econometrics & Business Statistics, Monash University, Clayton, Australia 
d School of Biosciences, the University of Melbourne, Melbourne, Australia 
e Allergy & Immune Disorders, Murdoch Children's Research Institute, the Royal Children's Hospital, Melbourne, Australia 
f School of Life and Environmental Sciences, Deakin University, Geelong, Australia 
g Monash Lung & Sleep, Monash Medical Centre and University and Hudson Institute, Melbourne, Australia 
h Department of Paediatrics, the University of Melbourne, Melbourne, Australia 
i Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia 

Corresponding author: Bircan Erbas, PhD, School of Public Health, La Trobe University, Rm 129, Health Sciences 1, Bundoora 3086, Victoria, Australia.School of Public Health, La Trobe UniversityRm 129, Health Sciences 1Bundoora3086, VictoriaAustralia

Abstract

Background

Childhood asthma is a significant public health problem and severe exacerbations can result in diminished quality of life and hospitalization.

Objective

We sought to examine the contribution of outdoor fungi to childhood and adolescent asthma hospitalizations.

Methods

The Melbourne Air Pollen Children and Adolescent study is a case-crossover study of 644 children and adolescents (aged 2-17 years) hospitalized for asthma. The Melbourne Air Pollen Children and Adolescent study collected individual data on human rhinovirus infection and sensitization to Alternaria and Cladosporium and daily counts of ambient concentrations of fungal spores, pollen, and air pollutants. Conditional logistic regression models were used to assess associations with increases in spore counts while controlling for potential confounding and testing interactions.

Results

Exposure to Alternaria (adjusted odds ratio [aOR], 1.07; 95% CI, 1.03-1.11), Leptosphaeria (aOR, 1.05; 95% CI, 1.02-1.07), Coprinus (aOR, 1.04; 95% CI, 1.01-1.07), Drechslera (aOR, 1.03; 95% CI, 1.00-1.05), and total spores (aOR, 1.05; 95% CI, 1.01-1.09) was significantly associated with child asthma hospitalizations independent of human rhinovirus infection. There were significant lagged effects up to 3 days with Alternaria, Leptosphaeria, Cladosporium, Sporormiella, Coprinus, and Drechslera. Some of these associations were significantly greater in participants with Cladosporium sensitization.

Conclusions

Exposures to several outdoor fungal spore taxa, including some not reported in previous research, are associated with the risk of child and adolescent asthma hospitalization, particularly in individuals sensitized to Cladosporium. We need further studies to examine cross-reactivity causing asthma exacerbations. Identifying sensitization to multiple fungal allergens in children with asthma could support the design and implementation of more effective strategies to prevent asthma exacerbations.

Le texte complet de cet article est disponible en PDF.

Key words : Outdoor fungi, asthma, hospitalization, child, adolescent, case-crossover design

Abbreviations used : aOR, HRV, MAPCAH, OR, PM2.5, PM10


Plan


 The Melbourne Air Pollen Children and Adolescent Health study was funded by the National Health and Medical Research Council (NHMRC) Project ID: 541934, but the NHMRC had no part in the study design, collection, analysis, or interpretation of the data, the writing of this manuscript, or the decision to submit it for publication. R.T. is funded by an NHMRC PhD Postgraduate Scholarship and a Centre for Air quality & health Research and evaluation (NHMRC Centre of Research Excellence) top-up scholarship. S.C.D. and A.J.L. are funded by the NHMRC.
 Disclosure of potential conflict of interest: R. Tham has received grants from the National Health and Medical Research Council (NHMRC) and the Center for Air quality & health Research and evaluation. S. C. Dharmage, A. J. Lowe, P. Bardin, M. L. K. Tang, M. J. Abramson, and B. Erbas have received grants from the NHMRC. E. Newbigin has received grants from the NHMRC and the Allergy Immunology Foundation of Australasia, has consultant arrangements with Ryco filters, and has received money from Stallergenes to support the Melbourne pollen count. M. J. Abramson holds investigator-initiated grants from Pfizer and Boehringer-Ingelheim for unrelated research, has undertaken an unrelated consultancy for AstraZeneca, and has received assistance with conference attendance from Boehringer-Ingelheim and Sanofi. The rest of the authors declare that they have no relevant conflicts of interest.


© 2016  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 139 - N° 4

P. 1140 - avril 2017 Retour au numéro
Article précédent Article précédent
  • Insights into the mast cell–microbiome connection in the skin
  • Alon Y. Hershko
| Article suivant Article suivant
  • Gene-based analysis of regulatory variants identifies 4 putative novel asthma risk genes related to nucleotide synthesis and signaling
  • Manuel A.R. Ferreira, Rick Jansen, Gonneke Willemsen, Brenda Penninx, Lisa M. Bain, Cristina T. Vicente, Joana A. Revez, Melanie C. Matheson, Jennie Hui, Joyce Y. Tung, Svetlana Baltic, Peter Le Souëf, Grant W. Montgomery, Nicholas G. Martin, Colin F. Robertson, Alan James, Philip J. Thompson, Dorret I. Boomsma, John L. Hopper, David A. Hinds, Rhiannon B. Werder, Simon Phipps, Australian Asthma Genetics Consortium Collaborators ‡

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.